Review
doi: 10.3233/JAD-2010-1238.
Why vitamin E therapy fails for treatment of Alzheimer's disease
Affiliations
- PMID: 20061623
- PMCID: PMC3023173
- DOI: 10.3233/JAD-2010-1238
Item in Clipboard
Review
Why vitamin E therapy fails for treatment of Alzheimer's disease
J Alzheimers Dis.
2010.
No abstract available
Comment on
-
Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.J Alzheimers Dis. 2009;17(1):143-9. doi: 10.3233/JAD-2009-1033. J Alzheimers Dis. 2009. PMID: 19494439 Clinical Trial.
Similar articles
-
Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.Int J Mol Sci. 2017 Nov 23;18(12):2504. doi: 10.3390/ijms18122504. Int J Mol Sci. 2017. PMID: 29168797 Free PMC article. Review.
-
The Effectiveness of Vitamin E Treatment in Alzheimer's Disease.Int J Mol Sci. 2019 Feb 18;20(4):879. doi: 10.3390/ijms20040879. Int J Mol Sci. 2019. PMID: 30781638 Free PMC article. Review.
-
Vitamin E for Alzheimer's disease?Geriatr Nurs. 2014 Mar-Apr;35(2):147-8. doi: 10.1016/j.gerinurse.2014.02.003. Geriatr Nurs. 2014. PMID: 24703434 No abstract available.
-
Is vitamin E the magic bullet for the treatment of Alzheimer's disease (AD)?Perspectives. 2000 Spring;24(1):7-10. Perspectives. 2000. PMID: 12026332 No abstract available.
-
Vitamin E in aging, dementia, and Alzheimer's disease.Biofactors. 2012 Mar-Apr;38(2):90-7. doi: 10.1002/biof.195. Epub 2012 Mar 16. Biofactors. 2012. PMID: 22422715 Review.
Cited by
-
Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.Neurochem Res. 2012 Dec;37(12):2706-14. doi: 10.1007/s11064-012-0860-8. Epub 2012 Aug 10. Neurochem Res. 2012. PMID: 22878647
-
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.Physiol Rev. 2024 Jan 1;104(1):103-197. doi: 10.1152/physrev.00030.2022. Physiol Rev. 2024. PMID: 37843394 Free PMC article. Review.
-
Vitamin E for Alzheimer's dementia and mild cognitive impairment.Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD002854. doi: 10.1002/14651858.CD002854.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Jan 27;1:CD002854. doi: 10.1002/14651858.CD002854.pub4. PMID: 23152215 Free PMC article. Updated.
-
Amyloid-beta neuroprotection mediated by a targeted antioxidant.Sci Rep. 2014 May 15;4:4983. doi: 10.1038/srep04983. Sci Rep. 2014. PMID: 24828380 Free PMC article.
-
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.J Clin Transl Res. 2021 Aug 4;7(4):575-620. eCollection 2021 Aug 26. J Clin Transl Res. 2021. PMID: 34541370 Free PMC article. Review.
References
-
- Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA. Redox proteomics identification of oxidized proteins in Alzheimer’s disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging. 2006;27:1564–1576. - PubMed
-
- Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol Aging. 1998;19:33–36. - PubMed
-
- Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–857. - PubMed
-
- Miller ER, III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
